Exelixis (EXEL) Invested Capital (2010 - 2026)
Exelixis (EXEL) recorded quarterly Invested Capital of $1.9 billion in Q2 2026, down 10.44% quarter-over-quarter from $2.2 billion in Q1 2026, and down 9.16% on a YoY basis from $2.1 billion in Q2 2025.
Exelixis (EXEL) Invested Capital (2010 - 2026) Analysis & Trends
Exelixis' Invested Capital history runs 17 years deep, the most recent figure standing at $1.9 billion for Q2 2026.
- In Q2 2026, Invested Capital fell 9.16% year-over-year to $1.9 billion; the TTM figure through Apr 2026 stood at $1.9 billion (down 9.16% YoY), while the FY2026 annual figure was $2.2 billion, down 3.69% from the prior year.
- Invested Capital was $1.9 billion for Q2 2026 at Exelixis, down from $2.2 billion in the prior quarter.
- In the past five years, Invested Capital ranged from a high of $2.6 billion in Q1 2023 to a low of $1.9 billion in Q2 2026.
- Historically, Invested Capital has averaged $2.3 billion across 5 years, with a median of $2.3 billion in 2023.
- The sharpest annual moves came in 2022 and 2024: Invested Capital advanced 20.02% in 2022, then slipped 16.72% in 2024.
- A 5-year view of Invested Capital shows it stood at $2.5 billion in 2022, then slipped by 9.02% to $2.3 billion in 2023, then advanced by 0.51% to $2.3 billion in 2024, then dropped by 5.04% to $2.2 billion in 2025, then dropped by 10.41% to $1.9 billion in 2026.
- The last three Invested Capital figures came in at $1.9 billion (Q2 2026), $2.2 billion (Q1 2026), and $2.2 billion (Q4 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | 7.14 Bn |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | 795.79 Mn |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | 595,226.00 |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 1.00 Bn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | 14.38 Mn |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 19.36 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | 502.95 Mn |
| 10 | Exelixis | 13.37 Bn | 12.59 Bn | 590.86 Mn | 1.94 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 3, 2026 | 1.94 Bn |
| Jan 2, 2026 | 2.16 Bn |
| Oct 3, 2025 | 2.16 Bn |
| Jul 4, 2025 | 2.03 Bn |
| Apr 4, 2025 | 2.13 Bn |
| Jan 3, 2025 | 2.24 Bn |
| Sep 27, 2024 | 2.28 Bn |
| Jun 28, 2024 | 2.12 Bn |
| Mar 29, 2024 | 2.13 Bn |
| Dec 29, 2023 | 2.26 Bn |
| Sep 29, 2023 | 2.35 Bn |
| Jun 30, 2023 | 2.53 Bn |
| Mar 31, 2023 | 2.56 Bn |
| Dec 30, 2022 | 2.49 Bn |
| Sep 30, 2022 | 2.49 Bn |
| Jul 1, 2022 | 2.39 Bn |
| Apr 1, 2022 | 2.29 Bn |
| Dec 31, 2021 | 2.21 Bn |
| Oct 1, 2021 | 2.11 Bn |
| Jul 2, 2021 | 2.04 Bn |